Indian pharma stocks drop 1% after Trump signs order to boost U.S. drug manufacturing

Aurobindo Pharma

06/05/2025 05:14

Corrects second bullet to say Nifty Pharma index has 20 members, not 10

** Indian pharma stocks .NIPHARM down 1.14%

** Eighteen stocks in 20-member Nifty Pharma index trade in the red

** U.S. President Donald Trump signed executive order overnight aiming to reduce time taken to approve pharmaceutical plants in the country

** Move meant to boost local drug manufacturing in U.S.

** Aurobindo Pharma ARBN.NS and Cipla CIPL.NS biggest losers, down 2.3% and 2.5%

** Heavyweights Sun Pharma SUN.NS, Dr. Reddys REDY.NS down over 1% each

** Most stocks on pharma index rated "hold" or "buy"

** Index has shed 8% so far this year

 (Reporting by Nandan Mandayam in Bengaluru)

 ((Nandan.Mandayam@thomsonreuters.com; Mobile: +91 9591011727;))